Providence Capital Advisors, LLC Amgen Inc Transaction History
Providence Capital Advisors, LLC
- $445 Million
- Q2 2024
A detailed history of Providence Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 48 shares of AMGN stock, worth $15,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48
Previous 45
6.67%
Holding current value
$15,168
Previous $12,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMGN
# of Institutions
3,073Shares Held
417MCall Options Held
7.19MPut Options Held
6.28M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.4 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.15 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.57 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.54 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $169B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...